Journal of Affective Disorders
Volume 118, Issue 1 , Pages 28-38 , November 2009

Fear of harm, a possible phenotype of pediatric bipolar disorder: A dimensional approach to diagnosis for genotyping psychiatric syndromes

  • Demitri Papolos

      Affiliations

    • Juvenile Bipolar Research Foundation, 22 Crescent Road, Westport, CT 06880, United States
    • Department of Psychiatry, Albert Einstein College of Medicine, United States
    • Corresponding Author InformationCorresponding author. Juvenile Bipolar Research Foundation, 22 Crescent Road, Westport, CT 06880, United States. Tel.: +1 203 246 1939; fax: +1 203 341 0496.
  • ,
  • Steven Mattis

      Affiliations

    • Department of Neurology, Weill-Cornell Medical Center, United States
    • Mattis & Luck Center for Neuropsychological Services, United States
    • Department of Neurology, Weil-Cornell Medical School, New York, United States
  • ,
  • Shahrokh Golshan

      Affiliations

    • Department of Psychiatry, University of California, San Diego, United States
  • ,
  • Francine Molay

      Affiliations

    • Juvenile Bipolar Research Foundation, 22 Crescent Road, Westport, CT 06880, United States

Received 6 January 2009 ,Revised 9 June 2009 ,Accepted 15 June 2009.

References 

  1. Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime?. Trends Genet. 2006;6:306–313
  2. Bellivier F. Genetic association studies. Definition of cases and controls. Methods Mol. Med. 2003;77:127–141
  3. Benedetti F, Dallaspezia S, Fulgosi MC, Barbini B, Colombo C, Smeraldi E. Phase advance is an actimetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiol. Int. 2007;24:921–937
  4. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J. Pediatric mania: a developmental subtype of bipolar disorder?. Biol. Psychiatry. 2000;48:458–466
  5. Biederman J, Faraone SV, Wozniak J, Mick E, Kwon A, Aleardi M. Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7years. J. Affect. Disord. 2004;82:S45–S58
  6. Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin. Infect. Dis. 2000;31(Suppl 5):S157–S161Oct
  7. Brown SL, Svrakic DM, Przybeck TR, Cloninger CR. The relationship of personality to mood and anxiety states: a dimensional approach. J. Psychiatr. Res. 1992;26:197–211
  8. Burdakov D, González JA. Physiological functions of glucose-inhibited neurons. Acta Physiol. (Oxf). 2008;71–78
  9. Capitani P, Cerri M, Amici R, Baracchi F, Jones CA, Luppi M, et al. Changes in EEG activity and hypothalamic temperature as indices for non-REM sleep to REM sleep transitions. Neurosci. Lett. 2005;383:182–187
  10. Charney DS, Barlow DH, Botteron K, Cohen JD, Goldman D, Gur RE, et al. Neuroscience research agenda to guide development of a pathophysiologically based classification system. In:  Kupfer DJ,  First MB,  Regier DA editor. A Research Agenda for DSM-V. American Psychiatric Association; 2002;
  11. Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol. Psychiatry. 2006;11:252–260
  12. Craney JL, Geller B. A prepubertal and early adolescent bipolar disorder-I phenotype: review of phenomenology and longitudinal course. Bipolar Disord. 2003;5:243–256
  13. Day DE, Keen-Rhinehart E, Bartness TJ. Role of NPY and its receptor subtypes in foraging, food hoarding, and food intake by Siberian hamsters. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005;289:R29–R36
  14. Day DE, Keen-Rhinehart E, Bartness TJ. Appetitive and consummatory ingestive behaviors stimulated by PVH and perifornical area NPY injections. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009;296:R877–R892
  15. De Fruyt F, De Clercq BJ, van de Wiele L, Van Heeringen K. The validity of Cloninger's psychobiological model versus the five-factor model to predict DSM-IV personality disorders in a heterogeneous psychiatric sample: domain facet and residualized facet descriptions. J. Pers. 2006;74:479–510
  16. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U. S. A. 1998;95:322–327
  17. Demeter CA, Townsend LD, Wilson M, Findling RL. Current research in child and adolescent bipolar disorder. Dialogues Clin. Neurosci. 2008;10:215–228
  18. Depue RA, Slater JF, Wolfstetter-Kausch H, Klein D, Goplerud E, Farr D. A behavioral paradigm for identifying persons at risk for bipolar depressive disorder: a conceptual framework and five validation studies. J. Abnorm. Psychol. 1981;90:381–437
  19. Dilsaver SC. Unsuspected depressive mania in pre-pubertal Hispanic children referred for the treatment of ‘depression’ with history of social ‘deviance’. J. Affect. Disord. 2001;67:187–192
  20. Douglass AB. Narcoplepsy: differential diagnosis or etiology in some cases of bipolar disorder and schizophrenia?. CNS Spectr. 2003;8:120–126
  21. Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiatry. 2006;60:93–105
  22. Ehlers CL, Somes C, Seifritz E, Rivier JE. CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depress. Anxiety. 1997;6:1–9
  23. Emeson RB, Morabito MV. Food fight: the NPY-serotonin link between aggression and feeding behavior. Sci. STKE. 2005;277:Pe12
  24. Engstrom C, Brandstrom S, Sigvardsson S, Cloninger R, Nylander PO. Bipolar disorder. II: Personality and age of onset. Bipolar Disord. 2003;5:340–348
  25. Eysenck HJ. Dimensions of Personality. Transaction Publishers; 1997;
  26. Faraone SV, Su J, Tsuang MT. A genome-wide scan of symptom dimensions in bipolar disorder pedigrees of adult probands. J. Affect. Disord. 2004;82:S71–S78
  27. Faraone SV, Lasky-Su J, Glatt SJ, Van Eerdewegh P, Tsuang MT. Early onset bipolar disorder: possible linkage to chromosome 9q34. Bipolar Disord. 2006;8:144–151
  28. Finegan JA. Study of behavioral phenotypes: goals and methodological considerations. Am. J. Med. Genet. 1998;81:148–155
  29. Fujiki N, Cheng T, Yoshino F, Nishino S. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice. Exp. Neurol. 2009;217:46–54
  30. Galvão MD, Sinigaglia-Coimbra R, Kawakami SE, Tufik S, Sucheck ID. Paradoxical sleep deprivation activates hypothalamic nuclei that regulate food intake and stress response. Psychoneuroendocrinology. 2009 Apr 3;34:1176–1183
  31. Geller B, Tillman R. Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria. J. Clin. Psychiatry. 2005;66:21–28
  32. Glavas MM, Grayson BE, Allen SE, Copp DR, Smith MS, Cowley MA, et al. Characterization of brainstem peptide YY (PYY) neurons. J. Comp. Neurol. 2008;506:194–210
  33. Goodwin FK, Jamison KR. Manic–Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd Ed.. USA: Oxford University Press; 2007;
  34. Gusnard DA, Ollinger JM, Shulman GL, Cloninger CR, Price JL, Van Essen DC, et al. Persistence and brain circuitry. Proc. Natl. Acad. Sci. U. S. A. 2003;100:3479–3484
  35. Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fear-potentiated startle. J. Neurosci. 2008;28:12682–12690
  36. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. U. S. A. 1999;96:10911–10916
  37. Hantouche EG, Akiskal HS. Toward a definition of a cyclothymic behavioral endophenotype: which traits tap the familial diathesis for bipolar II disorder?. J. Affect. Disord. 2006;96:233–237
  38. Harvey AG, Mullin BC, Hinshaw SP. Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev. Psychopathol. 2006;18:1147–1168
  39. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiatry. 2006;60:93–105
  40. Hirota K. Orexinergic neurons and noradrenergic awakening system in general anesthesia. Masui. 2007;56:9–18
  41. Holtmann M, Goth K, Wöckel L, Poustka F, Bölte S. CBCL-pediatric bipolar disorder phenotype: severe ADHD or bipolar disorder?. J. Neural Transm. 2008;115:155–161
  42. Horvath TL, Diano S, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 1999;19:1072–1087
  43. Jain MR, Horvath TL, Kalra PS, Kalra SP. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul. Pept. 2000;87:19–24
  44. Jiménez-Vasquez PA, Mathé AA, Thomas JD, Riley EP, Ehlers CL. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Brain Res. Dev. Brain Res. 2001;131:149–152
  45. Kalra SP, Kalra PS. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides. 2004;38:201–211
  46. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 1999;20:68–100
  47. Karl T, Lin S, Schwarzer C, Sainsbury A, Couzens M, Wittmann W, et al. Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc. Natl. Acad. Sci. U. S. A. 2004;101:12742–12747
  48. Keen-Rhinehart E, Bartness TJ. NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292:R1728–R1737
  49. Kehne JH. The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders. CNS Neurol. Disord. Drug Targets. 2007;6:163–182
  50. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psych. 2003;160:4–12
  51. Kim EY, Miklowitz DJ. Childhood mania, attention deficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas. Bipolar Disord. 2002;4:215–225
  52. Kishi T, Elmquist JK. Body weight is regulated by the brain: a link between feeding and emotion. Mol. Psychiatry. 2005;10:132–146
  53. Kraepelin E. Manic–Depressive Insanity and Paranoia. New York: Arno Press; 1976;
  54. Lack LC, Gradisar M, Van Someren EJ, Wright HR, Lushington K. The relationship between insomnia and body temperatures. Sleep Med. Rev. 2008;12:307–317
  55. Leboyer M, Bellivier F, McKeon P, Albus M, Borrman M, Perez-Diaz F, et al. Age at onset and gender resemblance in bipolar siblings. Psychiatry Res. 1998;81:125–131
  56. Leboyer M, Henry C, Paillere-Martinot ML, Bellivier F. Age at onset in bipolar affective disorders: a review. Bipolar Disord. 2005;7:111–118
  57. Leckman JF, Rauch SL, Mataix-Cols D. Symptom dimensions in obsessive–compulsive disorder: implications for the DSM-V. CNS Spectr. 2007;12:376–400
  58. Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS. Defining clinical phenotypes of juvenile mania. Am. J. Psychiatry. 2003;160:430–437
  59. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001;435:6–25
  60. Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive–compulsive disorder. Arch. Gen. Psychiatry. 2004;61:564–576
  61. Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive–compulsive disorder. Am. J. Psychiatry. 2005;162:228–238
  62. Mataix-Cols D, Pertusa A, Leckman JA. Issues for DSM-V: how should obsessive–compulsive and related disorders be classified?. Am. J. Psychiatry. 2007;164:1313–1314
  63. Mataix-Cols D, Nakatani E, Micali N, Heyman I. Structure of obsessive–compulsive symptoms in pediatric OCD. J. Am. Acad. Child Adolesc. Psych. 2008;47:773–778
  64. Mathew SJ, Price RB, Charney DS. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am. J. Med. Genet. C Semin. Med. Genet. 2008;148:89–98
  65. Mehl RC, et al. Correlates of sleep and pediatric bipolar disorder. Sleep. 2006;29:193–197
  66. Mehl RC, O'Brien LM, Jones JH, Dreisbach JK, Mervis CB, Gozal D. Correlates of sleep and pediatric bipolar disorder. Sleep. 2006;29:193–197
  67. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc. Natl. Acad. Sci. U. S. A. 2004;101:4649–4654
  68. Mishima, K., Fujiki, N., Yoshida, Y., Sakurai, T., Honda, M., Mignot, E., Nishino, S., 2008 Aug. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 1;31(8):1119–1126.
  69. Mochizuki T, Klerman EB, Sakurai T, Scammell TE. Elevated body temperature during sleep in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;291:R533–R540
  70. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M. National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch. Gen. Psychiatry. 2007;64:1032–1039
  71. Morrison SF, Nakamura K, Madden CJ. Central control of thermogenesis in mammals. Exp. Physiol. 2008;93:773–797
  72. Murphy, P., Cockerham, M., Papolos, D., in press. Parental reports of sleep disturbance in childhood onset bipolar disorder: comparison with children from community, sleep disorders clinic, and ADHD groups. Sleep.
  73. Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front. Neuroendocrinol. 2008;29:70–87
  74. Oldfield BJ, Allen AM, Davern P, Giles ME, Owens NC. Lateral hypothalamic ‘command neurons’ with axonal projections to regions involved in both feeding and thermogenesis. Eur. J. NeuroSci. 2007;25:2404–2412
  75. Olszewski PK, Shaw TJ, Grace MK, Höglund CE, Fredriksson R, Schiöth HB, et al. Complexity of neural mechanisms underlying overconsumption of sugar in scheduled feeding: involvement of opioids, orexin, oxytocin and NPY. Peptides. 2009;30:226–233
  76. Pal D, Mallick BN. Neural mechanism of rapid eye movement sleep generation with reference to REM-OFF neurons in locus coeruleus. Indian J. Med. Res. 2007;125:721–739
  77. Papolos DF. Bipolar disorder and comorbid disorders: the case for a dimensional nosology. In:  Geller B,  Delbello M editor. Bipolar Disorder in Childhood and Early Adolescence. NY, New York: The Guilford Press; 2003;
  78. Papolos D, Hennen J, Cockerham M. Obsessive fears about harm to self or others and overt aggressive behaviors in youth diagnosed with juvenile-onset bipolar disorder. J. Affect. Disord. 2005;89:99–105
  79. Papolos D, Hennen J, Cockerham MS. Factors associated with parent-reported suicide threats by children and adolescents with community-diagnosed bipolar disorder. J. Affect. Disord. 2005;86:267–275
  80. Papolos D, Hennen J, Cockerham MS, Thode HC, Youngstrom EA. The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder. J. Affect. Disord. 2006;95:149–158
  81. Papolos D, Hennen J, Cockerham MS, Lachman H. A strategy for identifying phenotypic subtypes: concordance of symptom dimensions between sibling pairs who met screening criteria for a genetic linkage study of childhood-onset bipolar disorder using the Child Bipolar Questionnaire. J. Affect. Disord. 2007;99:27–36
  82. Parmeggiani PL, Azzaroni A, Cevolani D, Ferrari G. Polygraphic study of anterior hypothalamic–preoptic neuron thermosensitivity during sleep. Electroencephalogr. Clin. Neurophysiol. 1986;63:289–295
  83. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing orexin (orexin) project to multiple neuronal systems. J. Neurosci. 1998;18:9996–10015
  84. Poceta JS, Parsons L, Engelland S, Kripke DF. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Sleep Med. 2009;10:129–133
  85. Preti A. Orexins (hypocretins): their role in appetite and arousal. Curr. Opin. Investig. Drugs. 2002;3:1199–1206
  86. Robison CL, Meyerhoff JL, Saviolakis GA, Chen WK, Rice KC, Lumley LA. A CRH1 antagonist into the amygdala of mice prevents defeat-induced defensive behavior. Ann. N.Y. Acad. Sci. 2004;1032:324–327
  87. Rodrigues SM, Le Doux JE, Sapolsky RM. The influence of stress hormones on fear circuitry. Annu. Rev. Neurosci. 2009;32, 289–313
  88. Schapiro NA. Bipolar disorders in children and adolescents. J. Pediatr. Health Care. 2005;19:131–141
  89. Silva AP, Xapelli S, Pinheiro PS, Ferreira R, Lourenço J, Cristóvão A, et al. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats. J. Neurochem. 2005;93:163–170
  90. Smoller JW, Tsuang MT. Panic and phobic anxiety: defining phenotypes for genetic studies. Am. J. Psychiatry. 1998;155:1152–1162
  91. Smoller JW, Gardner-Schuster E, Misiaszek M. Genetics of anxiety: would the genome recognize the DSM?. Depress. Anxiety. 2008;25:368–377
  92. Sørensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, During MJ, et al. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus. 2008;18:564–574
  93. Sørensen AT, Nikitidou L, Ledri M, Lin EJ, During MJ, Kanter-Schlifke I, et al. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp. Neurol. 2009;215:328–333
  94. Sosulina L, Schwesig G, Seifert G, Pape HC. Neuropeptide Y activates a G-protein-coupled inwardly rectifying potassium current and dampens excitability in the lateral amygdala. Mol. Cell. Neurosci. 2008;39:491–498
  95. Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 2000;62:161–168
  96. Szymusiak R, McGinty D. Hypothalamic regulation of sleep and arousal. Ann. N.Y. Acad. Sci. 2008;1129:275–286
  97. Tamas L, Horvath SD, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 1999;19:1072–1087
  98. Todd RD, Neuman R, Geller B, Fox LW, Hickok J. Genetic studies of affective disorders: should we be starting with childhood onset probands?. J. Am. Acad. Child Adolesc. Psych. 1993;32:1164–1171
  99. van Praag HM. Diagnosis, the rate-limiting factor of biological depression research. Neuropsychobiology. 1993;28:197–206
  100. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 2001;74:683–701
  101. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 2001;24:429–458
  102. Xapelli S, Agasse F, Ferreira R, Silva AP, Malva JO. Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Patents CNS Drug Discov. 2006;1:315–324
  103. Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000;859:404–409
  104. Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003;38:701–713
  105. Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, et al. Fluctuation of extracellular orexin-1 (orexin A) levels in the rat in relation to the light–dark cycle and sleep–wake activities. Eur. J. NeuroSci. 2001;14:1075–1081
  106. Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. (Maywood). 2001;226:468–476
  107. Youngstrom E, Youngstrom JK, Starr M. Bipolar diagnoses in community mental health: Achenbach Child Behavior Checklist profiles and patterns of comorbidity. Biol. Psychiatry. 2005;58:569–575
  108. Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452:997–1001

PII: S0165-0327(09)00279-1

doi: 10.1016/j.jad.2009.06.016

Journal of Affective Disorders
Volume 118, Issue 1 , Pages 28-38 , November 2009